A036220 Stock Overview
Researches, develops, and sells various diagnostic biosensors in South Korea and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Osang Healthcare Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩11,840.00 |
52 Week High | ₩45,000.00 |
52 Week Low | ₩9,720.00 |
Beta | 0.43 |
1 Month Change | 3.86% |
3 Month Change | -8.22% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -65.65% |
Recent News & Updates
Shareholder Returns
A036220 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -0.08% | -3.2% | -3.7% |
1Y | n/a | -3.0% | -10.4% |
Return vs Industry: Insufficient data to determine how A036220 performed against the KR Medical Equipment industry.
Return vs Market: Insufficient data to determine how A036220 performed against the KR Market.
Price Volatility
A036220 volatility | |
---|---|
A036220 Average Weekly Movement | 5.7% |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.6% |
10% most volatile stocks in KR Market | 12.7% |
10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A036220 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A036220's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 334 | Man-Suk Ko | www.osanghc.com |
Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide.
Osang Healthcare Co.,Ltd Fundamentals Summary
A036220 fundamental statistics | |
---|---|
Market cap | ₩162.35b |
Earnings (TTM) | -₩13.97b |
Revenue (TTM) | ₩75.71b |
2.1x
P/S Ratio-11.6x
P/E RatioIs A036220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A036220 income statement (TTM) | |
---|---|
Revenue | ₩75.71b |
Cost of Revenue | ₩50.29b |
Gross Profit | ₩25.42b |
Other Expenses | ₩39.39b |
Earnings | -₩13.97b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.02k |
Gross Margin | 33.58% |
Net Profit Margin | -18.45% |
Debt/Equity Ratio | 0% |
How did A036220 perform over the long term?
See historical performance and comparisonDividends
16.9%
Current Dividend Yield-182%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 11:41 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Osang Healthcare Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kidal Bae | Shinhan Investment Corp. |